37497-86-2

Usage

Uses

Used in Pharmaceutical Industry:
METHYL 1-CHLORO-4-ISOQUINOLINECARBOXYLATE is used as a building block for the synthesis of various biologically active compounds, such as antimalarial and anticancer drugs, due to its versatile chemical structure and potential therapeutic properties.
Used in Antimalarial Applications:
METHYL 1-CHLORO-4-ISOQUINOLINECARBOXYLATE is used as a precursor in the development of antimalarial drugs, contributing to the synthesis of compounds that can effectively combat malaria-causing parasites.
Used in Anticancer Applications:
METHYL 1-CHLORO-4-ISOQUINOLINECARBOXYLATE is used as a starting material for the synthesis of anticancer drugs, potentially aiding in the development of novel therapeutic agents that target various types of cancer.
Used in Anti-inflammatory Applications:
METHYL 1-CHLORO-4-ISOQUINOLINECARBOXYLATE is used as a potential anti-inflammatory agent, with its properties being explored for the development of treatments that can alleviate inflammation and associated symptoms.
Used in Antiviral Applications:
METHYL 1-CHLORO-4-ISOQUINOLINECARBOXYLATE is used as a potential antiviral agent, with its properties being investigated for the development of treatments that can combat viral infections and their associated complications.

InChI:InChI=1/C11H8ClNO2/c1-15-11(14)9-6-13-10(12)8-5-3-2-4-7(8)9/h2-6H,1H3

Upstream product

• 37497-84-0 1-Oxo-1,2-dihydroisochinolin-4-carbonsaeure-methylester 

Downstream Products

• 340005-99-4 methyl 3-Phenyl-1,2,4-triazolo[3,4-a]isoquinoline-6-carboxylate 
• 1233249-52-9 methyl 1-[(4-methoxyphenyl)carbonyl]isoquinoline-4-carboxylate 
• 1233249-63-2 methyl [1-({4-[2-(4-chlorophenyl)ethoxy]phenyl}carbonyl)isoquinolin-4-yl]acetate 
• 1233248-18-4 2-[1-[4-[3-(4-chlorophenyl)propoxy]benzoyl]isoquinolin-4-yl]acetic acid 
• 1233248-17-3 2-[1-[4-[2-(4-chlorophenyl)ethoxy]benzoyl]isoquinolin-4-yl]acetic acid 
• 1233248-13-9 2-[1-[4-[2-(3,4-dichlorophenyl)ethylcarbamoyl]benzoyl]isoquinolin-4-yl]acetic acid 
• 1233248-16-2 2-[1-[4-[(4-chlorophenyl)carbamoyl]benzoyl]isoquinolin-4-yl]acetic acid 
• 1233249-36-9 methyl 1-{4-(tert-butoxycarbonylamino)phenylcarbonyl}isoquinolin-4-ylcarboxylate 
• 1233249-90-5 methyl 1-[[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]methyl]isoquinoline-4-carboxylate 
• 1233249-87-0 methyl 1-(4-{[2-(4-chlorophenyl)ethyl]sulfamoyl}benzyl)isoquinoline-4-carboxylate 
• 1233250-21-9 methyl 1-(4-{[2-(4-chlorophenyl)ethyl]carbamoyl)phenoxy)isoquinoline-4-carboxylate 
• 1233249-53-0 1-[(4-methoxyphenyl)carbonyl]isoquinoline-4-carboxylic acid 
• 1233248-11-7 2-[1-[4-[2-(4-chlorophenyl)ethylcarbamoyl]benzoyl]isoquinolin-4-yl]acetic acid 
• 1233249-62-1 methyl {1-[(4-{[2-(4-chlorophenyl)ethyl]carbamoyl}phenyl)carbonyl]isoquinolin-4-yl} acetate 

Relevant academic research and scientific papers

Bicyclic and tricyclic heteroaromatic compounds

Disclosed are compounds of the formula: and the pharmaceutically acceptable salts thereof, wherein W, Q, X, X1, Y and Z are as defined herein. These compounds bind with high selectivity and/or high affinity to the benzodiazepine site of GABAsu